Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of $10.68 billion. The enterprise value is $12.46 billion.
| Market Cap | 10.68B |
| Enterprise Value | 12.46B |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Exact Sciences has 181.53 million shares outstanding. The number of shares has increased by 2.15% in one year.
| Shares Outstanding | 181.53M |
| Shares Change (YoY) | +2.15% |
| Shares Change (QoQ) | -1.60% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 87.00% |
| Float | 179.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.27 |
| Forward PS | 3.70 |
| PB Ratio | 3.40 |
| P/FCF Ratio | 334.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 238.70, with an EV/FCF ratio of 390.25.
| EV / Earnings | n/a |
| EV / Sales | 4.98 |
| EV / EBITDA | 238.70 |
| EV / EBIT | n/a |
| EV / FCF | 390.25 |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.81.
| Current Ratio | 2.32 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 48.94 |
| Debt / FCF | 80.01 |
| Interest Coverage | -9.37 |
Financial Efficiency
Return on equity (ROE) is -6.60% and return on invested capital (ROIC) is -3.77%.
| Return on Equity (ROE) | -6.60% |
| Return on Assets (ROA) | -3.20% |
| Return on Capital (ROIC) | -3.77% |
| Revenue Per Employee | $378,752 |
| Profits Per Employee | -$30,932 |
| Employee Count | 6,600 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 5.32 |
Taxes
In the past 12 months, Exact Sciences has paid $2.40 million in taxes.
| Income Tax | 2.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.11% in the last 52 weeks. The beta is 1.23, so Exact Sciences's price volatility has been higher than the market average.
| Beta (1Y) | 1.23 |
| 52-Week Price Change | -6.11% |
| 50-Day Moving Average | 63.28 |
| 200-Day Moving Average | 70.11 |
| Relative Strength Index (RSI) | 36.06 |
| Average Volume (30 Days) | 2,495,890 |
Short Selling Information
The latest short interest is 9.89 million, so 5.45% of the outstanding shares have been sold short.
| Short Interest | 9.89M |
| Short Previous Month | 6.34M |
| Short % of Shares Out | 5.45% |
| Short % of Float | 5.51% |
| Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, Exact Sciences had revenue of $2.50 billion and -$204.15 million in losses. Loss per share was -$1.13.
| Revenue | 2.50B |
| Gross Profit | 1.85B |
| Operating Income | -215.01M |
| Pretax Income | -201.75M |
| Net Income | -204.15M |
| EBITDA | 52.20M |
| EBIT | -182.30M |
| Loss Per Share | -$1.13 |
Balance Sheet
The company has $777.64 million in cash and $2.55 billion in debt, giving a net cash position of -$1.78 billion or -$9.79 per share.
| Cash & Cash Equivalents | 777.64M |
| Total Debt | 2.55B |
| Net Cash | -1.78B |
| Net Cash Per Share | -$9.79 |
| Equity / Book Value | 3.15B |
| Book Value Per Share | 17.33 |
| Working Capital | 679.67M |
Cash Flow
In the last 12 months, operating cash flow was $156.12 million and capital expenditures -$124.19 million, giving a free cash flow of $31.93 million.
| Operating Cash Flow | 156.12M |
| Capital Expenditures | -124.19M |
| Free Cash Flow | 31.93M |
| FCF Per Share | $0.18 |
Margins
Gross margin is 73.83%, with operating and profit margins of -8.60% and -8.17%.
| Gross Margin | 73.83% |
| Operating Margin | -8.60% |
| Pretax Margin | -8.07% |
| Profit Margin | -8.17% |
| EBITDA Margin | 2.09% |
| EBIT Margin | -7.29% |
| FCF Margin | 1.28% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.15% |
| Shareholder Yield | -2.15% |
| Earnings Yield | -1.91% |
| FCF Yield | 0.30% |
Analyst Forecast
The average price target for Exact Sciences is $91.14, which is 54.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $91.14 |
| Price Target Difference | 54.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 13.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.6 |
| Piotroski F-Score | 4 |